Furthermore, in the presence of anti-PDL1 checkpoint blockade therapy, tumor-associated antigens could induce a robust anti-tumor immune response and effectively inhibit tumor metastasis (Figure 7A). This evidence concerns the gene CD274 and neoplasm.